Rituximab therapy in adults with steroid-dependent nephrotic syndrome

INTRODUCTION: Patients with steroid-dependent nephrotic syndrome (SDNS) suffer frequent relapse with adverse effects caused by long-term prednisolone treatment. Recently, the chimeric monoclonal antibody against the protein CD20 (rituximab – RTX) was observed to be efficacious and safe in the treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Hongzhen, Li, Hong-Yan, Zhou, Tianbiao, Weng, Wenjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Systematic review/Meta-analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259397/
https://www.ncbi.nlm.nih.gov/pubmed/37313189
http://dx.doi.org/10.5114/aoms.2019.88404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259397/
https://www.ncbi.nlm.nih.gov/pubmed/37313189
http://dx.doi.org/10.5114/aoms.2019.88404

Ejemplares similares